Literature DB >> 9418125

Induction of humoral and cellular immunity against influenza virus by immunization of newborn mice with a plasmid bearing a hemagglutinin gene.

A Bot1, S Antohi, S Bot, A Garcia-Sastre, C Bona.   

Abstract

Neonates and infants display an intrinsic disability to mount protective immune responses to influenza viruses or conventional influenza vaccines. We investigated the ability of naked DNA to prime protective immune responses by inoculating newborn and adult mice with a plasmid (pHA) expressing hemagglutinin (HA) from the neurovirulent strain A/WSN/33 of influenza virus. Continuous exposure to small doses of antigen subsequent to neonatal DNA immunization led to effective priming of specific B and Th cells, rather than tolerance induction. The pHA immunization of adult mice primed a strongly biased Th1 response, whereas in neonates it induced a mixed Th1/Th2 response. In contrast to the effect of live-virus immunization, DNA immunization of neonates was followed by enhanced cytotoxic T lymphocyte responses subsequent to challenge with A/WSN/33 influenza virus. Mice immunized as neonates or adults with pHA plasmid exhibited significant increases in survival and decreases in virus lung titers following lethal challenge with the A/WSN/33 virus or the A/PR8/34 drift variant. Our results demonstrate that DNA vaccination is an efficient and safe means to generate broad humoral and cellular immune responses to influenza viruses, during the earliest stages of postnatal life.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9418125     DOI: 10.1093/intimm/9.11.1641

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  11 in total

Review 1.  Expression library immunization: a road map for discovery of vaccines against infectious diseases.

Authors:  Adel M Talaat; Katherine Stemke-Hale
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

2.  Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines.

Authors:  Shixia Wang; Jessica Taaffe; Christopher Parker; Alicia Solórzano; Hong Cao; Adolfo García-Sastre; Shan Lu
Journal:  J Virol       Date:  2006-09-20       Impact factor: 5.103

3.  CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice.

Authors:  C L Brazolot Millan; R Weeratna; A M Krieg; C A Siegrist; H L Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

4.  Design of a heterosubtypic epitope-based peptide vaccine fused with hemokinin-1 against influenza viruses.

Authors:  Shahla Shahsavandi; Mohammad Majid Ebrahimi; Kaveh Sadeghi; Homayoon Mahravani
Journal:  Virol Sin       Date:  2015-04-15       Impact factor: 4.327

Review 5.  Advances in novel influenza vaccines: a patent review.

Authors:  Jae-Min Song
Journal:  J Microbiol       Date:  2016-05-27       Impact factor: 3.422

6.  The key regulators of adult T helper cell responses, STAT6 and T-bet, are established in early life in mice.

Authors:  Shawn Rose; Patricia Guevara; Sandra Farach; Becky Adkins
Journal:  Eur J Immunol       Date:  2006-05       Impact factor: 5.532

7.  Protective T-cell-based immunity induced in neonatal mice by a single replicative cycle of herpes simplex virus.

Authors:  M Franchini; C Abril; C Schwerdel; C Ruedl; M Ackermann; M Suter
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

8.  CpG-induced Th1-type response in the downmodulation of early development of allergy and inhibition of B7 expression on T cells of newborn mice.

Authors:  Cyro A de Brito; Ana E Fusaro; Jefferson R Victor; Paula O Rigato; Adriana L Goldoni; Bruno P Muniz; Alberto J S Duarte; Maria N Sato
Journal:  J Clin Immunol       Date:  2010-01-19       Impact factor: 8.317

9.  Murine neonates develop vigorous in vivo cytotoxic and Th1/Th2 responses upon exposure to low doses of NIMA-like alloantigens.

Authors:  Shannon J Opiela; Robert B Levy; Becky Adkins
Journal:  Blood       Date:  2008-06-06       Impact factor: 22.113

10.  Genetic vaccine for tuberculosis (pVAXhsp65) primes neonate mice for a strong immune response at the adult stage.

Authors:  Ana Cláudia Pelizon; Douglas R Martins; Sofia F G Zorzella; Ana Paula F Trombone; Júlio C C Lorenzi; Robson F Carvalho; Izaíra T Brandão; Arlete A M Coelho-Castelo; Célio L Silva; Alexandrina Sartori
Journal:  Genet Vaccines Ther       Date:  2007-11-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.